Rate and duration of hospitalization for deep vein thrombosis and pulmonary embolism in real-world clinical practice

Ann Med. 2015;47(7):546-54. doi: 10.3109/07853890.2015.1085127. Epub 2015 Sep 30.

Abstract

Background: Current guidelines recommend initial treatment with anticoagulants at home in patients with acute deep vein thrombosis (DVT) and in patients with low-risk pulmonary embolism (PE) with adequate home circumstances. However, most of the patients with acute venous thromboembolism (VTE) are currently hospitalized regardless of their risk of short-term complications.

Aim of the study: To assess the proportion of outpatients with acute VTE initially treated in hospitals, to assess the mean duration of hospitalization, and to identify predictors for in-hospital or home treatment.

Methods: Data of Italian patients enrolled in the RIETE registry from January 2006 to December 2013 were included.

Results: Altogether 766 PE and 1,452 isolated DVT were included. Among PE patients, mean PESI score was 84 points (SD 35), and 56% of patients had a low-risk PESI score (<85). In all, 53.7% of DVT and 17.0% of PE were entirely treated at home, and 38.2% of DVT patients and 19.9% of PE patients were hospitalized for ≤5 days. On multivariate analysis, low PESI score was not independently associated with the hospitalization of PE patients.

Conclusions: One in every two patients with DVT and five in every six with PE are still hospitalized.

Keywords: Hospitalization; treatment; venous thromboembolism.

Publication types

  • Multicenter Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acute Disease
  • Adult
  • Aged
  • Anticoagulants / administration & dosage
  • Anticoagulants / therapeutic use*
  • Female
  • Hospitalization / statistics & numerical data*
  • Humans
  • Italy
  • Length of Stay
  • Male
  • Middle Aged
  • Multivariate Analysis
  • Outpatients
  • Practice Guidelines as Topic
  • Pulmonary Embolism / drug therapy*
  • Registries
  • Venous Thrombosis / drug therapy*

Substances

  • Anticoagulants